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A famous British professor, Andrew Bush, often emphasizes – Why? How? So what? – in 
connection to research. The questions could be applied in wider perspectives and were central 
to me when I decided to become a PhD-student.   
 
Why should a middle-aged clinician, without the need for an additional career, double the 
workload? 
During the years as a clinician, I have often been concerned about the lack of knowledge on 
how to care for and how to treat the respiratory symptoms seen in growing children born 
preterm. In the evolving research friendly environment at Sachsska, I realized that I had the 
possibility to in some way contribute to that ―black whole‖. 
 
How? 
The ―perfect storm‖ struck me. The hospital provided the infant lung function equipment. My 
colleges Magnus and Gunnar got me started.  Jenny and Erik were the perfect catalyst.  
 
So what? 
Personally, this has been a joyful experience and given me new insights, not only to research.  
Hopefully, some of the results of the studies in the thesis actually put some new knowledge 
into the ―black whole‖ I wanted to explore. 
 
Per Thunqvist 2016 
  
  
  
  
ABSTRACT 
The prevalence of preterm birth (ie., before 37 weeks of gestation) is increasing and 
estimated to be around 11 % worldwide. In high-income countries, survival is the most 
probable outcome even after extreme preterm deliveries. Children born preterm exhibit 
different stages of lung immaturity at birth and follow-up studies have shown lung function 
impairment and respiratory morbidity, including asthma-like disease, during infancy and into 
adulthood. Asthma or asthma-like disease is common in the general pediatric population. 
Differentiation of early childhood asthma phenotypes demonstrates different underlying 
pathophysiologic mechanisms and trajectories with age. 
 
The general aims of the present thesis were:  
- To investigate lung function from infancy to adolescence in relation to preterm birth and 
asthma in early childhood.  
- To investigate if similarities and differences in measured lung function after preterm birth 
and among childhood asthma phenotypes may give information on mechanisms for the 
obstructive patterns seen in these different conditions. 
 
Longitudinal follow-up during the first 18 months of life of infants with bronchopulmonary 
dysplasia (BPD) showed significant reductions of lung function in the cohort.  Maximal 
expiratory flows were on average below the 2.5
th
 percentile for both mild and 
moderate/severe BPD at both 6 and 18 months, with the exception VmaxFRC at 6 months and 
no improvement was seen between the two time-points. Compliance of the respiratory system 
(COso) was the only lung function variable that differed statistically between mild and 
moderate/severe BPD, with lower values for the more severe disease. Significant lower 
values were consistently seen for Cso and all maximal expiratory variables in infants with 
respiratory symptoms compared to infants without.  
In a follow-up of children born extremely preterm (before gestational week 27), a subset of 
the population based cohort EXPRESS, performed lung function at age 6½ years.  The 
extreme preterm children had lower forced expiratory volume in 1 sec (FEV1, z-score: -1.1, 
95% CI: -1.4; -0.8) than the control group born at term. Impulse oscillometry (IOS) 
measurements showed significantly higher peripheral airway resistance and reactance in 
children born extremely preterm than in controls. In children born at 22-24 weeks of 
gestation, 44% had FEV1 below the <5
th
 percentile. 
Using the BAMSE cohort study, lung function after moderate-to-late preterm birth was 
investigated at 8 and 16 years of age. At age 16 years, both genders in the preterm group 
demonstrated lower FEV1 (female subjects: –116 mL [95 % CI: –212 to –20]; male subjects: 
–177 mL [95 % CI: –329 to –25]) compared with the term group. IOS demonstrated higher 
frequency dependence of resistance (R5-20) for male subjects (20.9 Pa・L–1・s−1 [95 % CI: 
9.8 to 31.9]) compared with the term group. No catch up of lung function between ages 8 and 
16 years was observed in either gender. 
In the last study, children taking part in the BAMSE cohort study were categorized into 
‗never asthma‘, ‗early transient asthma‘, ‗early persistent asthma‘, and ‗late onset asthma‘ 
and lung function data from the 8 and 16 year follow-ups was used to compare groups. 
Compared with the never asthma group, all asthma groups were associated with lower FEV1 
at 16 years of age (early transient—119 ml, 95% confidence interval 204 to 34; early 
persistent—410 ml, 95 %CI 533; 287; and late onset—148 ml, 95%CI  237; 58). R5-20 was 
significantly associated with active asthma at 16 years, but not transient asthma. 
 
In conclusion: 
- A significant proportion of children born very and extreme preterm have lung 
function values below the normal range in infancy and at at early scool-age. Lung 
function in adololescense is lower after moderate-to-late preterm birth than after term. 
- Staging BPD severity did not predict lung function. 
- Early measured lung function is associated with respiratory morbidity in children with 
BPD. 
- IOS identifies children with low lung function after preterm birth and those with 
active pediatric asthma. 
 
Clinical remark: 
Measurements of lung function may identify children at risk for respiratory morbidity and 
provide insights into long-term sequel of preterm birth. Regular assessments of lung function 
from infancy, during childhood and possibly throughout life, are therefore suggested to be an 
important tool when monitoring individuals born preterm. 
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Stockholm, Epidemiology 
Continuous Positive Airway Pressure 
Cso Single occlusion method for compliance of the respiratory 
system 
EXPRESS Extremely Preterm Infants in Sweden Study 
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FEV0.5 Forced expiratory volume at 0.5 seconds 
FEV1 Forced expiratory volume at 1 second 
FOT Forced Oscillation Technique 
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FVC Forced Expiratory Volume 
IFLT Infant Lung Function Test 
IOS Impulse Oscillometry, a variant of FOT (see below) 
MEF50 Maximal expiratory flow at 50 % of FVC 
R20 Resistance at 20 Hz 
R5 Resistance at 5 Hz 
RVRTC Raised Volume Rapid Thoracic Compression, ―raised 
squeeze‖ 
TVRTC Tidal Volume Rapid Thoracic Compression, ―tidal squeeze‖ 
V´maxFRC Maximal forced expiratory flow at FRC 
X Reactance 
Zrs Respiratory system impedance 
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1 INTRODUCTION 
 
 
Early life exposures and insults to the respiratory system are recognized to have 
consequences on respiratory health during childhood and in later life.(1, 2) Preterm birth is a 
common event that has impact on lung function development and respiratory health during 
childhood and into adulthood.(3, 4) The burden of health from preterm birth, defined as birth 
before 37 (< 36+6) completed weeks of gestation, is substantial and increasing in most 
regions of the world that have access to reliable data.(5) The prevalence of preterm birth is 
estimated to be around 11 percent worldwide and ranging from 18 percent in some African 
countries to five percent in high-income countries like Sweden. A further division of preterm 
birth into extremely preterm (< 28 weeks), very preterm (28 to <32 weeks), and moderate-to-
late preterm (32 to <37 weeks) is important, since lower gestational age is associated with 
increasing mortality and morbidity. The vast majority are moderate-to-late preterm births, 
while 1 – 2 percent are born very or extremely preterm.(5, 6) In the Swedish national study 
cohort EXPRESS (Extremely Preterm Infants in Sweden Study) the incidence of extremely 
preterm birth (< 27 weeks of gestation) was 3/1 000 infants.(7) Further, infant survival is 
nowadays the most probable outcome after extremely preterm birth (8) and the burden of 
respiratory morbidity after preterm birth could therefore be assumed to increase in the future. 
Very preterm birth (< 32 weeks of gestation) is associated with three times increased risk of 
childhood wheezing disorder compared with term birth.(4) Respiratory disease after preterm 
birth shares some clinical and pathophysiological features with asthma, such as airway 
obstruction, airway hyper-responsiveness and susceptibility to respiratory wheezing.(9, 10) 
Even though asthma is now described as a heterogeneous disease, it is usually characterized 
by chronic airway inflammation (GINA guidelines 2015). Airway inflammation is not a 
feature of the asthma-like disease seen after preterm birth and it has been suggested that the 
word asthma should be avoided when describing the chronic pulmonary disease seen after 
preterm birth.(11, 12)  
Asthma or asthma-like syndrome after term birth is common in young children and 
prevalence of current asthma is reported to be 8 – 9 % at school age.(13) Prevalence 
estimations in younger children are often based on epidemiological studies that include data 
on respiratory wheeze.(14) To aid in management and treatment of asthma or asthma-like 
disease, a number of asthma phenotypes has been suggested.(15) Epidemiological studies 
have identified asthma phenotypes with early onset of asthma-like symptoms and impairment 
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of lung function that track throughout life, not only in those with persisting symptoms, but 
also after early transient symptoms.(16) The transient early wheeze phenotype is common 
during the first years of life, with declining prevalence during the preschool period, and is not 
associated with allergic inflammation.(17)  
Whether or not asthma-like syndrome after preterm birth could be described as an asthma 
phenotype is a matter of opinion. Anti-asthma drugs are commonly prescribed, though have 
not yet been proven effective in treating the asthma-like symptoms in this growing group of 
symptomatic children and adults. It is not known if the longstanding effects on lung function 
development after preterm birth and in children with the transient early wheeze phenotype 
share pathophysiological mechanisms, but the bronchial obstructive pattern and absence of 
airway inflammation in both entities make comparisons reasonable. 
 
 
2 BACKGROUND 
 
2.1 NORMAL LUNG DEVELOPMENT 
 
By volume, the lungs are the largest organs in the body, but consist of only half a liter of 
tissue. The structures of the lungs separate approximately half a liter of blood from a certain 
volume of air, which varies during the course of normal breathing. The configuration of the 
lungs allows a minimum of tissue to create a fairly stable surface for gas exchange, at nearly 
the size of a tennis court, inside a limited space (thorax cavity). The human airway tree 
consists of on average 23 generations of branches. Generation 0 (trachea) to approximately 
generation 15 are lined with bronchial epithelium and functionally named conducting 
airways. In the conducting airways, which hold less than a tenth of the resting lung volume, 
i.e.functional residual capacity, no gas exchange takes place. From airway generations 15 – 
16, alveoli with gas-exchanging surfaces start to appear. As branching continues, the alveoli 
increase in numbers, and in the last generation, alveolar sacs form blind endings.(18) 
Generations 15 – 23 are called the acinar airways and hold the vast majority of the resting air 
volume. Functionally, the acinar airways serve as the gas-exchanging zone.  Bronchial 
generations 8/9 to 23 are for practical reasons called peripheral or small airways.(Figure 1)  
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Figure 1. Schematic cartoon of the airway tree (by courtesy of Per Gustafsson). 
 
The prenatal lung development is divided into four characteristic periods. A fifth period, the 
so called alveolar period, continues postnatally.(19) The first prenatal period, the embryonic 
period (weeks 0 – 6), starts with an epithelial tube, derived from the foregut, which branches 
into the surrounding mesenchyme to form two lung buds. From the mesenchyme, smooth 
muscle and blood vessels arise, which follow the dichotomous branching taking place during 
the period. At the end of the stage, the five main lung lobes and 18 lobules are present. 
During the next period, the pseudo-glandular period (weeks 7 – 16), branching of airways 
and vessels continues and at the end of the stage conducting airways and pre-acinar vascular 
pattern are completed. The canalicular period (weeks 17 – 24) involves further development 
of distal airways and appearance of rudimentary alveoli. During this stage, the thin air-blood 
barrier is formed and early secretion of surface-active agents into air spaces occurs, creating 
pre-conditions for survival ex utero. In the saccular period (weeks 24 – 36/40), the last 
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generation of airways, the alveolar duct and, at the end of the period, the alveoli are formed. 
True alveoli start to appear from week 32. The pulmonary surfactant system develops, starts 
to mature and is increasingly active after the 32
nd
 gestational week. The last four to five 
weeks before term, the alveolar period, is characterized by a large increase of gas-exchanging 
surface. At birth alveolarization has barely started – numbers ranging from 50 to 150 million 
alveoli have been suggested – and most of this further formation of alveoli takes place after 
birth at term.(20) The length of the alveolar period has lately been debated. Previously, 
alveoli have been thought to stop multiplying at between 2 – 7 years of age.(21) However, 
recent human studies suggest that the process might continue into adulthood, which 
completely changes the perspective on alveolar repair.(22, 23) The final numbers of alveoli in 
adults are in the range of 300 to 800 million depending on lung size and sex.(24) From birth 
and up to early adulthood (around 22 years of age in men and slightly earlier in females), the 
lung size increases proportionally with body size and is affected by sex, age and 
ethnicity.(25) This enormous development is described to represent a 30-fold increase in gas-
exchanging surface and at least a doubling of airway diameter and length.    
 
2.2 LUNG FUNCTION AFTER PRETERM BIRTH 
 
Understanding normal lung development is essential in order to comprehend the different 
responses of the airways to insults during fetal life or after birth. The short version of this 
section could be that ―the outcome of aberrant lung development depends on the type, 
severity, and duration of insult, and the developmental stage at which it occurs.‖(20) Another 
important cornerstone for the understanding is the concept of tracking lung function during 
growth.(26, 27) This implies that infants born with impaired lung function, due to in utero or 
extra-uterine insults, will usually remain at a low percentile for measured lung function from 
childhood to adulthood.  
 
Initially the effects of preterm birth were described in terms of airway epithelial metaplasia, 
peribronchial fibrosis, vascular smooth muscle hyperplasia and radiologic findings in infants 
suffering from severe respiratory distress syndrome. This description of the clinical picture 
after preterm birth was named bronchopulmonary dysplasia (BPD) by Northway et al. in 
1967.(28) After advances in peri- and neonatal care over the last decades, this description 
only applies to a minority of patients today and is now referred to as ―old BPD‖. The ―new‖ 
BPD seen in children born today is characterized by disrupted alveolar and vascular 
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growth.(29) The purpose of diagnosing BPD in infants in the neonatal period could be 
summarized as serving to enable prediction of length of neonatal care, requirement of oxygen 
therapy, severity of future respiratory morbidity and lung function impairments, and to aid 
develop of effective preventive and treatment strategies for respiratory syndrome following 
preterm birth.(30, 31) To define BPD in the neonatal period, the need for prolonged 
supplemental oxygen delivery during the first period of life was suggested as a surrogate 
marker for the disease. Several options of this definition of BPD have been proposed over the 
years. The most commonly accepted definition used in recent studies for infants born before 
32 weeks of gestation is based on the need for supplementary O2 therapy at 28 days of age, 
and severity is determined at 36 weeks of gestation as follows:  
 
Mild BPD - breathing room air  
Moderate BPD - breathing < 30 % oxygen 
Severe BPD - need for ≥ 30 % supplementary oxygen and/or CPAP or ventilator use.(32)  
 
Whether or not mild BPD should be included at all in the definition is debated. Guidelines 
from the Swedish Neonatal Society, published by the National Board of Health and Welfare, 
define BPD as the need for supplemental oxygen at gestational week 36, at least if an infant is 
born very preterm.  
The feasibility and criticism of use of BPD diagnosis, irrespective of severity levels, as a 
prognostic tool for future respiratory morbidity will be discussed later. There is little evidence 
that BPD relates to specific histopathology, whereas preterm birth seems to do so, as 
presented below. 
 
The pathogenesis of functional abnormalities seen after preterm birth is complex. The main 
features in lung function at follow-up after preterm birth, not limited to BPD, are increased 
airway resistance, reduced compliance of the respiratory system, hyperinflation, airway 
obstruction, and bronchial hyper-responsiveness.(3, 9, 10, 33, 34) Infants born very or 
extremely preterm are born in the canalicular and early saccular stages of lung development, 
when the conducting airways are already developed, and thus vulnerable to insults. Airway 
wall dimensions have been shown to be increased in infants who died from BPD, compared 
with infants who died from SIDS (sudden infant death syndrome).(35) Structural and 
histologic studies of airways in surviving infants after preterm birth are, for obvious reasons, 
not common. In animal models, airway smooth muscle hyperplasia and airway remodeling 
have been described after hyperoxia.(36) Being born before alveolar formation is thought to 
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lead to alveolar arrest, resulting in fewer and larger alveoli after preterm birth. This has been 
shown in infants during the first years of life.(37) However, the arrest after preterm birth is 
not thought to be  permanent.(29) Recently, studies using 
3
Helium MRI have shown 
intriguing results that suggest that alveolar development continues both in healthy children 
and after preterm birth into adulthood.(22, 23) This is supported by Yammine et al., who 
found normal alveolar compartment function at school age in former pre-terms using the 
multiple-breath washout technique.(38) They also reported that impairments in convection-
dependent airways (peripheral conducting airways) could influence the obstructive pattern 
seen after preterm birth. Further support for airway wall involvement in pathology after 
preterm birth was presented by Henschen et al., who concluded that the physical ability of the 
airways to carry flow differs in children born preterm compared with in those born at term, 
and that the difference cannot be explained merely by the size of the airways.(39) In 
conclusion, in spite of some encouraging findings in recent years, all preterm births are 
associated with altered and reduced lung function. The complex relationship between lung 
function and structural deficits is thus still only partially understood.   
2.3 ASTHMA PHENOTYPES IN EARLY LIFE IN RELATION TO LUNG 
FUNCTION 
 
It is well recognized that asthma is not a single disease, but many, with large variations in 
disease course and outcome. From this knowledge, the concept of asthma phenotypes has 
evolved in the last decades. The purpose of phenotyping is to aid development of preventive 
strategies and treatment. The term asthma phenotype describes observed properties or 
developmental traits of the disease. It can encompass a number of biochemical, clinical and 
physiological measures, which describe the characteristics of the phenotype, without any 
reference to a particular pathophysiological process. It is likely that most of the airways, from 
the central to the most peripheral structures, could be involved in asthma, suggesting different 
pathophysiology behind a common clinical feature. Asthma endotypes describe the 
underlying pathological mechanisms. An asthma phenotype is not the result of one single 
endotype, but of several, and conversely a specific endotype could give rise to several 
phenotypes.(40) This implies that ―one size fits all‖ concepts for asthma treatment and 
prevention will fail and indicates the need for targeted approaches.  
 
One approach of phenotyping is to use the relationship between asthma course and lung 
function. Martinez et al. identified three latent asthma phenotypes based on the presence or 
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absence of respiratory wheeze during the first six years of life; transient early, persistent and 
late-onset wheeze. They found that transient early wheeze was associated with lower lung 
function, measured using spirometry soon after birth, and remained lower than that of never 
wheezers at follow-up in adolescence.(14, 41) Persistent wheezers had maximal expiratory 
flows, which were initially no different from those of non-wheezers, but lower at follow-up in 
adolescence. Finally, the late-onset wheezers had lung function similar to that of non-
wheezers, both early after birth and at adolescence. When using more complex approaches 
than a single presenting symptom, other asthma phenotypes have been identified.(17) 
Nevertheless, latent asthma phenotypes, based on symptoms or biological measures, are 
retrospective and provide important information on disease, but have limited utility for 
clinicians as a prognostic tool. In the absence of evidence for symptom-defined asthma 
phenotypes and discrete pathophysiological processes in children, studies using other lung 
function techniques that are more sensitive to peripheral airways than spirometry could aid 
decisions in the clinical setting. Both inert gas washout and the IOS technique – the latter 
used in our studies – have been associated with asthma control during childhood. Singer et al. 
showed abnormal acinar ventilation distribution in children with asthma despite normal 
spirometry.(42) Similarly, Shi et al. found increased frequency dependence of resistance and 
reactance in uncontrolled subjects as compared with subjects with controlled asthma, despite 
spirometry findings were not different in asthmatics and healthy controls.(42, 43) These 
techniques therefore have the potential to be clinical tools for identifying individuals who 
could benefit from more intense treatment or interventions. However, it is fair to appreciate 
that lung function only partly represents the features of a clinical asthma phenotype. It is 
likely that asthma phenotypes in the future will be based on much more complex information 
than symptoms and lung function, such as genetics, airway inflammation markers and 
recorded environmental exposures.    
 
2.4 LUNG FUNCTION TESTING 
 
Objective assessment of lung function is an important component in the diagnosis, 
management and understanding of respiratory disorders. Information on lung function in the 
growing child yields information concerning: 
 
- Lung growth and development 
- Quantitiative measure of impairment (mild, moderate, severe disease) 
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- Physiological processes involved  
- Effects of interventions 
- Epidemiologic evaluations of risk factors for disease 
 
There are several components of the airway walls and the lung parenchyma that could be 
affected in the developing lung. Several methods have been developed over the past century 
to assess abnormalities of these structures, with a boost of techniques in the last few decades 
thanks to the rapid development of computer processing. Possible pathophysiological 
findings in airway obstruction after preterm birth or in early childhood asthma are 
abnormalities in airway smooth muscle, airway thickness and airway compliance. To assess 
this in the present thesis, we have used a mixture of methods, applied from infancy to late 
adolescence.  
2.4.1 Infant lung function testing (ILFT) 
 
The first attempts to measure lung function in infants were made in 1890. The first infant 
plethysmograph was used in the 1960s in London. During the 1980s, techniques to measure 
passive lung mechanics and maximal expiratory flows were developed. Generally, ILFT is 
still mainly used in research, while routine clinical use is still considered limited and not yet 
fully established. Among the limitations are the need for sedation, expensive equipment, a 
time-consuming procedure requiring intensive training of staff and limited available reference 
values. In brief, the IFLT protocol in Study 1 consisted of the single breath single occlusion 
method for measuring respiratory system compliance (Cso) by passive lung mechanics, 
whole body plethysmography for measuring functional residual capacity (FRC), and forced 
expiratory flow volume loops using the tidal volume rapid thoracic compression (TVRTC) 
and raised volume rapid thoracic compression (RVRTC) methods. The tests were performed 
with the subject wearing a face mask over the nose and mouth and lying in the supine 
position during quiet sleep after sedation with chloral hydrate (60 – 100 mg/kg body weight).  
 
The single occlusion technique to measure compliance of the respiratory system, Cco, is based 
on the ability to invoke the Hering Breuer inflation reflex. If the airway is occluded above 
FRC, the reflex leads to a period of relaxation of respiratory muscles and a prolonged relaxed 
expiration.(44) During this brief period, pressures can equilibrate across the respiratory 
system so that alveolar pressure can be measured at airway opening. Cso is assumed to mainly 
  9 
reflect the elastic recoil pressure of the lung, thus giving information on the elastic properties 
of the lung. This is due to the highly compliant chest wall in first years of life. 
FRC is determined through whole body plethysmography, which measures all gas in the 
lungs at the end of expiration, including any trapped gas behind closed airways. The basic 
principal is based on Boyle‘s law, which states that for a fixed mass, the product of pressure 
and volume of a gas are constant.(45) Increased values of FRC indicate trapped gas due to 
intrathoracic airway obstruction and decreased values could in infancy indicate congenital 
problems or disrupted alveolar development.  
Rapid thoracic compression (RTC) method, often referred to as the ―squeeze‖method, 
measures flow limitations and is be performed during tidal breathing at the end of inspiration 
(Tidal Volume RTC, TVRTC) or at the end of a maximal inspiration (Raised Volume RTC, 
RVRTC).(46) The raised volume is produced by applying a pressure of 30 cm H2O to the 
airway and is considered to be equal to a maximal voluntary inspiration. To obtain forced 
expiratory flows, the infant is made to exhale at a maximal rate by compressing the thorax 
using an inflatable jacket. Determinates of flow are the elastic recoil of the lung, the chest 
wall, airway dimensions and airway stability. TVRTC measures flow at resting volume, 
VmaxFRC, which means that values reflect either airway properties or lung volume or both. 
Flow measures by the RVRTC method mimics conventional spirometry and are more closely 
related to flows measured later during childhood and adulthood. Time flows, such as forced 
expiratory volume at 0.5 sec, are commonly reported. RVRTC also produces the forced 
expiratory volume, FVC, maximal expirable volume after a maximal inspiration. This 
volume, in contrast to FRC, does not include trapped gas.  
 
Figure 2. Infant lung function test (photo by P Thunqvist) 
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No single infant lung function test can on its own be used to fully characterize physiological 
and mechanical properties; the use of several tests is often indicated.   
 
2.4.2 Dynamic spirometry 
 
Forced expiratory volume measurements in relation to time were first described by Robert 
Tiffeneau in 1947. Since then, dynamic spirometry has become the most used and established 
lung function method in both clinical settings and research. There is an extensive, well-
recognized body of tutorials and standardization literature on spirometry.(47) 
 
Dynamic spirometry (Figure 3) measures the maximal volumes and flows that can be inhaled 
and exhaled by an individual. Forced expiratory volume (FVC) is the volume change 
between a full inspiration and a maximal forced expiration. FVC represents the size of the 
lungs, but does not include the volume left in the lung after airway closure. Thus, a low value 
indicates small lungs or air-trapping. To measure the volume left in the lungs after a maximal 
exhalation either a plethysmographic or a gas-washout technique is required. 
The maximal expiratory flow volumes curves are based on the assumption of reaching flow 
limitation during the maximal expiration maneuver. If increasing expiratory effort is applied 
to the airway and no further increase of flow is seen, flow limitation has been achieved. A 
low flow, compared with reference values or healthy control subjects, indicates higher 
resistance or smaller airway caliber, which is characteristic of airway obstruction. Dynamic 
spirometry reports volumes at different time points during exhalation, typically at 1 second 
(FEV1) in older children and adults and at 0.5 second in infants (FEV0.5). Flow is also 
reported and referenced to a specific volume, typically flow at 50 % of FVC (MEF50). 
Expired volumes at specific time points, particularly FEV1, have proven to be robust and less 
variable than flows at specific volumes and are therefore preferred as a measure of lung 
function. Finally, the ratio between FEV1 and FVC (FEV1/FVC) is reported as a measure of 
proportionality between airway dimension and lung volumes. A low ratio is seen in airway 
obstruction and a high ratio indicates a restrictive lung pattern in the presence of low lung 
volume.  
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Figure 3. Dynamic spirometric flow volume loop (by courtesy of Per Gustafsson) 
 
2.4.3 Impulse oscillometry (IOS) 
  
IOS is a commercially available forced oscillation technique (FOT). FOT was first described 
by Dubois in 1956 (interestingly in the same time span as dynamic spirometry).(48) The 
principal of FOT is that respiratory mechanics can be measured using superimposition of 
external pressure oscillations to the respiratory system during tidal breathing, which is a very 
slow oscillatory process. The output, which is a complex relationship of the artificial pressure 
waves from the loudspeaker and the test subject‘s tidal breathing waveform, is called 
respiratory impedance (Zrs) and represents mechanical properties of the respiratory system 
(rs).(49) The IOS system applies complex sound pulses 5 times per second to the airways. 
Sophisticated signal processing by Fast Fourier Transform (FFT) analysis used by the 
software resolves Zrs with respect to frequency of the sound waves, giving a spectrum of Zrs 
from 5 to 35 Hz, and extrapolates data even down to 3 Hz. Zrs can be separated into its two 
components resistance (R) and reactance (X). R represents energy loss due to ―friction‖, 
while X represents energy captured by the respiratory system . X has two components: 
capacitive reactance, also called capacitance (C), and inertive reactance, also called inertance  
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(I). Capacitance relates to the energy stored when the walls of the respiratory system, 
including the airways and the chest wall, are forced to widen in response to the pressure force 
put on them. Thus, it is related to the elements of the lungs determining compliance. 
Inertance reflects the energy required to accelerate the air column in the airways, C and I 
represent opposing forces. At lower frequencies of the sound wave C predominates, while I 
predominates at higher frequencies. At an intermediate frequency, called the resonant 
frequency (fres), C and I are balanced and X equals zero. The area under the curve of X from 
5Hz to fres is called the area of reactance (AX). It was introduced by the American respiratory 
physiologist Michael D Goldman and is sometimes referred to as Goldman´s triangle (Figure 
4). The use of multiple oscillation frequencies allows a separation of large and smaller airway 
resistance. Higher frequencies (> 20 Hz) travel shorter distances and can only reach large or 
intermediate airways. Lower frequencies (< 15 Hz) are transmitted more distally in the lungs. 
As a result, low frequencies represent small and large airways, and higher frequencies 
represent only large airways. R, is in healthy adults nearly independent of oscillation 
frequency (R is equal at low and high Hz). In young children and adults with peripheral 
airway obstruction, R is higher at low frequencies, compared to high frequencies; this 
phenomenon is called frequency-dependence of resistance (fdR). In practice, fdR is an index 
of bronchial obstruction and is expressed as the resistance at 5 Hz less the resistance at 20 Hz 
(R5-20). Similarly, low frequencies of the sound wave X therefore represents elastic properties 
in the periphery.    
AX correlates with fdR and is used as a sensitive index of peripheral airway obstruction.(50)  
Forced oscillation techniques have the advantage over spirometry that they minimize 
demands on the patient, requiring only passive cooperation and making the techniques 
feasible to children too young to perform spirometry or for other reasons unable to perform a 
expiratory maneuver.  
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 Figure 4. Schematic illustration of components of impedance (Z) in a healthy subject 
with absent frequency dependence of resistance ( by courtesy of Per Gustafsson) 
 
 
 
2.5 TREATMENT OF OBSTRUCTIVE DISEASE  
 
Treatment of pediatric asthma 
Updated local and international guidelines for treatment of asthma in childhood have been 
published (Global initiative for asthma, Läkemedelsverket 2015, Barnallergisektionen 2015). 
However, treatment of early infant wheeze, most often trigged by viral respiratory infections 
is less evidence based and still widely discussed.(51) As noted above, identifying asthma 
phenotypes early in life with an increased risk of developing persistent obstructive disease is 
challenging.(16) In the absence of sensitive and specific predictive algorithms to identify who 
will and who will not respond to regular asthma treatment, it is likely that a significant 
proportion of early asthma patients given treatment suggested by guidelines will not 
respond.(15)  
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Treatment of asthma-like symptoms after preterm birth 
There are no published guidelines available regarding treatment of respiratory symptoms, 
often described as asthma-like, in children or adults born preterm. In clinical practice, it is 
common that conventional asthma treatment is used, even though the scientific background is 
almost non-existing.   
Anti-inflammatory treatment for patients born preterm has been investigated in three studies. 
A four-week crossover study with 400 microgram budesonide daily at 8 years of age in 
preterm children (mean gestational age 28 weeks) had no effect on respiratory symptoms or 
airway function during the active period.(52) Pelkonen et al. studied a similar preterm group 
at 10 years of age. They demonstrated reduced lung function, increased responsiveness to 
beta2-agonists and/or increased diurnal peak expiratory flow before the start of the study. 
After 4 months of inhaled corticosteroid therapy (800 microgram budesonide daily) they 
found no effect on clinical outcome or spirometric values, but some effect on peak expiratory 
flow (PEF) variation.(53)  
Several studies have addressed exercise-induced bronchoconstriction in preterm children and 
reported significant bronchodilation of beta2-agonist after exercise.(54, 55) However, since 
none of these studies used treatment before exercise, it remains unclear if asthma treatment 
has any role in preventing exercise-induced bronchial obstruction.  
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3 OBJECTIVES 
 
Overall aims 
 To determine lung function development from infancy to adolescence in relation to 
preterm birth and asthma in early childhood.  
 To investigate if similarities and differences in measured lung function after preterm 
birth and among childhood asthma phenotypes may provide information on 
mechanisms for the obstructive patterns seen in these different conditions. 
 
 
Specific research questions 
 What is the effect of preterm birth on lung function in infancy (Study 1), school age 
(Study 2), and adolescence (Study 3)? 
 What is the relationship between early staging of BPD severity and subseqent 
measured lung function (Study 1, Study 2)? 
 What are the long-term effects on lung function development after preterm birth 
(Study 1, Study 2, Study 3)? 
 What is the association between different childhood asthma phenotypes and lung 
function (Study 4)?  
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4 SUBJECTS AND METHODS 
4.1 STUDY POPULATIONS AND DESIGN 
 
The study subjects included in the present thesis are participants in one of three different 
cohorts. The preterm infant study (Study 1) is based on subjects from Sachs‘ Children and 
Youth Hospital and represent a longitudinal cohort study of patients recruited 2006 – 2008. 
Subjects in the early school-age preterm study (Study 2) were recruited from a national birth 
cohort (EXPRESS), a prospective cohort study of extremely premature children with case-
control design. The moderate-to-late preterm study (Study 3) and the early asthma study 
(Study 4) are based on the prospective birth cohort BAMSE and include longitudinal follow-
up data. 
4.1.1 Preterm infant study population (Study 1)  
 
During 2006 – 2008, 58 prematurely born children (gestational weeks 23 – 30) diagnosed 
with BPD and admitted to the Neonatal Units at Sachs‘ Children and Youth Hospital were 
recruited to the study. They were consecutively invited to follow-ups, including lung 
function tests, at 6 and 18 months postnatal age. The parents of 55 infants agreed to 
participate in the study.  
4.1.2 School-age preterm study population (Study 2) 
 
EXPRESS (Extremely Preterm Infants in Sweden Study) included all infants in Sweden born 
before 27 weeks of gestation between April 1 2004 and March 31 2007.(7, 56) In three out of 
seven health care regions in Sweden, all participants in the EXPRESS study were invited to a 
follow-up at 6½ years of age (± 3 months). In total, 250 children (51 % of the total EXPRESS 
cohort alive at the time of inclusion) were eligible for inclusion. Thirty-four children were 
lost to follow-up and 38 declined participation, leaving 178 children who were included in the 
study. 
4.1.3 Moderate-to-late preterm (Study 3) and early childhood asthma study 
populations (Study 4) 
 
The study populations in Studies 3 and 4 are both derived from the BAMSE (Swedish 
abbreviation for Children, Allergy, Milieu, Stockholm, Epidemiology) cohort, which is a 
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prospective birth cohort including 4 089 Swedish children.(58) The plan was initially to 
establish risk factors for allergy-related disease in childhood up to the age of 4 years.(57) 
Since then, several follow-ups have been performed and a investigation at 24 years of age is 
currently being planned.  Parents of all infants born between 1994 and 1996 in predefined 
areas of Stockholm, including inner city, urban and suburban districts were asked to 
participate in the study. The original cohort consisted of 75 % of eligible children. Exclusion 
criteria were: the family planned to move within one year of the study start; insufficient 
knowledge of the Swedish language; the family had a seriously ill child; or an older sister or 
brother was already included in the study. Data on detailed residential characteristics, 
environmental factors, and allergic heredity were collected through parental questionnaires 
when the children were approximately two months of age (time of inclusion). At 1, 2, 4, 8, 12 
and 16 years of age, questionnaires focusing on symptoms and medications related to 
respiratory and allergic diseases were administered, with response rates ranging from 82 – 96 
% at each occasion. The participants have been invited to follow-ups that included lung 
function assessments at three occasions: 4, 8 and 16 years of age. At 4 years of age, 2 599 
children successfully took part in testing that included Peak Expiratory Flow (PEF) 
measures.(59). Acceptable spirometry was performed in 1 832 children at 8 years of age.(60). 
At 16 years of age, all subjects were invited to follow-ups including both spirometry and IOS. 
The study samples in Studies 3 and 4 differ somewhat and are described below. 
In Study 3, data from questionnaires at 2.5 months (baseline), 8 years and 16 years, and lung 
function at 8 and 16 years of age were used. After exclusion of children born very and 
extremely preterm (< gestational week 32, n = 24) and post-term (> gestational week 42, n = 
373), 3 692 subjects (90 % of the original BAMSE cohort) were eligible for the study. Of 
those, 2 782 participated in the 8- and/or 16-year follow-up and were included in the study. 
In Study 4, data from questionnaires at 2.5 months (baseline), 1, 2, 4, 8 and 16 years of age 
and lung function from 8 and 16 years were used. Of the 2 605 subjects participating in the 
16-year follow-up, 2 355 (90 %) had sufficient data on wheeze/asthma to be classified into 
the predefined asthma groups (see below), and were included in the study. 
 
 
4.2 DEFINITIONS OF STUDY GROUPS 
 
Preterm infant study group definitions (Study 1)  
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The participants were children born preterm between gestational weeks 23 – 30 and 
diagnosed as having BPD in the neonatal period. Perinatal and neonatal data were obtained 
from medical records. The diagnosis of BPD was based on the need for supplementary O2 
therapy at 28 days of age, and severity was determined at 36 weeks of gestation as follows: 
Mild BPD - breathing room air. 
Moderate/severe BPD - need for supplementary oxygen, at least more than room air and/or 
CPAP or ventilator use.(32) 
 
School-age preterm group definitions (Study 2) 
Children in the preterm group were all born extremely preterm, from week 22 and before 
week 27. Perinatal and neonatal data were obtained from the EXPRESS study.(7) 
Bronchopulmonary dysplasia (BPD) in the neonatal period was categorized as either 
moderate BPD (breathing > 21 % but < 30 % oxygen) or severe BPD (breathing at least 30 % 
oxygen and/or CPAP) at 36 weeks of postmenstrual age.(32) Small for gestational age (SGA) 
was defined as a birth weight two standard deviations or more below the mean, and 
appropriate for gestational age (AGA) was defined as birth weight within two standard 
deviations of the mean, based on a Swedish sex and gestational age-specific reference for 
normal fetal growth.(61) 
Using the Swedish Medical Birth Register, each preterm child was matched to a randomly 
selected healthy control born at term (gestational age 37 – 41 weeks). Matched factors were 
mother‘s country of birth, date of delivery, hospital of birth and sex. 
 
Moderate-to-late preterm study group definitions (Study 3) 
The participants were divided into two groups categorized by gestational age (GA), 
moderate-to-late preterm (32 – 36 weeks) and term (37 – 41 weeks). GA was obtained from 
the Swedish Medical Birth Registry or, when registry data was not available, by parental 
reporting in the baseline questionnaire.   
 
Early childhood asthma study group definitions (Study 4) 
The children were separated into symptom groups based on data about asthma and/or wheeze 
onset and duration from the questionnaires at 1, 2, 4, 8 and 16 years of age. The following 
definitions were used: ‘never asthma‘ (reference group, did not fulfill any asthma criteria 
from birth to 16 years of age), ‗early transient asthma‘ (asthma between age 0 and 4 years, 
no wheeze after), ‗early persistent‘ (asthma in the first 4 years and asthma at 16 years), and 
‗late-onset asthma‘ (no asthma at ages 1, 2, or 4, but asthma at age 16). 
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4.3 DEFINITIONS OF ASTHMA AND RESPIRATORY OUTCOMES 
 
Preterm infant study respiratory outcomes (Study 1) 
In order to classify participants into symptom or no-symptom groups, details on ongoing 
and previous respiratory symptoms, such as recurrent or chronic cough, wheeze, breathing 
problems and medication for respiratory symptoms, were obtained from parents in follow-
ups at 6 and 18 months of age and from hospital-based medical records.  
 
School-age preterm study respiratory outcomes (Study 2) 
Information on asthma-like disease, defined as respiratory wheeze in the previous 12 months 
and/or current use of asthma medication (beta2-agonists, inhaled corticosteroids, 
antileukotrienes) in the previous 12 months, was obtained through questionnaires filled out at 
the time of follow-up.  
 
Moderate-to-late preterm study respiratory outcomes (Study 3) 
Asthma was defined as fulfilling at least two of the following three criteria; 1) symptoms of 
wheeze during the 12 months prior to the date of questionnaire, 2) doctor‘s diagnosed asthma 
(from birth to the date of the questionnaire), 3) asthma medication taken occasionally or 
regularly during the 12 months prior to the date of questionnaire.(62) Wheeze was defined as 
at least one episode of wheeze during the 12 months prior to the date of the questionnaire.  
 
Early childhood asthma study respiratory outcomes (Study 4) 
Asthma at age 1 and 2 years was defined as at least 3 episodes of wheezing in the previous 12 
months, combined with either inhaled steroid therapy or signs of airway hyper-reactivity 
(wheezing or severe coughing at excitement or cold weather, or disturbing cough at night) 
without ongoing cold. For subjects at 4, 8 and 16 years of age, the definition of asthma was at 
least 3 episodes of wheezing in the previous 12 months, or 1 episode if the child had been 
given inhaled steroid therapy.(63) Wheeze was defined as one or more episodes of 
wheezing in the previous 12 months. 
4.4 LUNG FUNCTION TESTS 
4.4.1 Infant lung function tests in Study 1 
Lung function tests were performed with the subject in the supine position during quiet sleep 
after sedation with chloral hydrate (60 – 100 mg/kg administered orally or rectally) using the 
Master Screen Baby BodyPlethysmograph (Erich Jaeger AG, Würtzburg, Germany). The 
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lung function protocol included four types of measurements: Passive lung mechanics 
measuring compliance of the respiratory system by a single occlusion method (Cso),(44) lung 
volume at functional respiratory capacity (FRC) by whole body plethysmography,(64) 
maximal flow at FRC, VmaxFRC from a partial expiratory flow-volume loop (TVRTC) and 
from raised volume technique (RVRTC) forced expiratory volume (FVC), forced expiratory 
volume at 0.5 sec (FEV0.5) and mid-expiratory flow (MEF50) were obtained.(46) The 
procedures for the measurements are described in detail elsewhere.(64-66) Briefly, Cso 
results were reported as the highest value from three acceptable recordings and accepted 
curves had to have a plateau during occlusion of 100 ms and linearity of the flow volume 
curve during expiration of r
2
 > 0.98. FRC was measured during at least two end-inspiratory 
occlusions by whole body plethysmography and calculated from at least two technically 
acceptable measurements. VmaxFRC, was reported as the highest technically acceptable 
recordings, where no further increments of air into the bladder under the non-elastic vest 
resulted in higher flow. For RVRTC variables, the jacket pressure producing the highest 
flow during TVRTC was used. Analysis was performed on the values for FVC, FEV0,5 and 
MEF50 from the maneuver having the highest sum of FEV0,4 and FVC.  
4.4.2 Spirometry in Studies 2 – 4.  
When subjects were 6½ years (Study 2) and 16 years (Studies 3 and 4), spirometry was 
performed using the Jaeger MasterScreen-IOS system (Carefusion Technologies, San Diego, 
CA, USA).(67) When subjects were 8 years of age (Studies 3 and 4), lung function testing 
was performed using the 2200 Pulmonary Function Laboratory (Sensormedics, Anaheim, 
CA, USA). Spirometry was performed according to ATS/ERS criteria at all occasions.(47) 
The participant performed at least three MEFV (Maximum Expiratory Flow Volume) 
recordings in the sitting position, wearing a nose clip. The highest values of FVC and FEV1 
were extracted and used for analysis, provided that the participant‘s effort was evaluated as 
being maximal by the test leader, the MEFV curve passed visual quality inspection, and 
provided that the two highest FVC and FEV1 and MEF50 (Studies 2 and 3) readings were 
reproducible according to the ATS/ERS criteria. FEV1/FVC ratios were expressed as 
percentages. The spirometry system was calibrated each day using a 3 L precision syringe. 
4.4.3 Impulse oscillometry (IOS) in Studies 2 – 4 
IOS measurements were performed using Jaeger MasterScreen-IOS system (Carefusion 
Technologies, San Diego, CA, USA).(67) The IOS system has been described in detail 
elsewhere.(49, 68) Briefly, the IOS system generates small pressure oscillations to the 
airways through a loudspeaker and the software measures respiratory impedance, which 
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includes the respiratory resistance (Rrs) and respiratory reactance (Xrs). All IOS 
measurements were performed during tidal breathing with the child sitting in an upright 
position, with lips sealed around the mouthpiece and cheeks supported by the hands. For each 
participant, a minimum of two recordings lasting at least 20 seconds, without artefacts, were 
saved for later analysis. Quality control was performed at the time of the examination by 
visual inspection of the waveforms. Recordings with sighs, swallows and coughs were not 
accepted. A coherence between recordings of > 0.80 at 10 Hz was used as the criterion for an 
appropriately performed test. The mean value of the resistance at 5 Hertz (R5), the resistance 
at 20 Hertz (R20), the frequency dependence of resistance (fdR, i.e. R5-20) and the area under 
the curve of negative reactance values (AX) were calculated off-line. AX was reported in 
Study 2. In Studies 3 and 4, AX
0.5
 was used to report reactance instead. AX may boost the 
assessed response inappropriately compared with the R5-20 response, because it multiplies two 
partly independent reactions of the airways. We therefore ―linearized‖ AX in Studies 3 and 4 
by reporting its square root as well (―AX0.5‖). The IOS system was calibrated each day with a 
reference resistance of 0.20 kPa·L
-1
·s
-1
. 
4.4.4 Measures of bronchodilator response in Study 3 
Pulmonary function after bronchodilation was measured using both methods (spirometry, 
IOS as described above), approximately 20 minutes after an inhaled dose of salbutamol (4 x 
100 microgram Airomir®, Teva) through a valved spacer device. 
 
4.5  STATISTICAL METHODS 
Analyses in all studies were performed with the Stata 12.1 software package (StataCorp LP, 
College Station, TX, USA). 
In all four presented studies, a p-value < 0.05 was considered to be statistically significant. 
Infant preterm study statistics (Study 1) 
Demographic, perinatal data and differences in symptoms were compared between groups 
(BPD severity groups, symptom groups) of children using Student‘s t-tests or the Pearson 
chi-square test. Each individual lung function test result was converted to a z-score using 
published reference equations.(69-71) Abnormal lung function was defined as a z-score lower 
than 1.96. For comparison with other studies, Cso and FRC were also reported as units per kg 
body weight. Differences in lung function according to BPD severity or symptoms were 
assessed using the Mann–Whitney rank sum test. Lung function change over time was 
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assessed by comparing z-scores between 6 and 18 months using the Wilcoxon matched-pairs 
signed-rank test.  
 
School-age preterm study statistics (Study 2)   
Demographic and perinatal data are reported as means and standard deviations, ranges or 
proportions and percentages. Comparisons between the preterm and control groups were 
performed using the Student‘s t-test or the Pearson chi-square test. Lung function in the 
different groups of children was assessed using multiple linear regression analyses, adjusting 
group comparisons for age and height at the time of measurement, examination site and sex. 
FVC, FEV1 and FEV0.75 were converted to z-scores using the Global Lung Initiative 
reference values (GLI).(25) The lower limit of normal (LLN) was defined as z-scores for 
FEV1 below -1.64 (< 5
th
 percentile) and -1.96 (< 2.5
th
 percentile),(25) respectively, and the 
odds for children born preterm having a FEV1 below these LLN values were calculated using 
logistic regression analysis.  
 
Moderate-to-late preterm study and Early childhood asthma study statistics (Studies 3 – 4) 
Demographic data, mean height and weight at time of examination were compared between 
groups of children using Student‘s t-tests or the Pearson chi-square test. In Study 3, the 
associations between term/preterm groups and spirometry variables were assessed through 
linear regression analysis and IOS variables were assessed through quantile regression 
analysis, for males and females separately, adjusting for age and height at the time of 
measurement. IOS variables were also adjusted for maternal smoking. Since the distribution 
of the values of IOS was skewed to the right we utilized quantile regression (72, 73), also 
called regression on the median, to estimate associations between groups and IOS variables. 
In Study 4, the associations between asthma groups and lung function (spirometry/IOS) 
variables were assessed using linear regression analysis adjusted for age, height, weight and 
sex. In Study 4, we also performed quantile regression on the median for IOS data. 
In Study 3, associations between preterm birth and z-scores of FEV1 according to the Global 
Lung Initiative reference values (GLI) were also evaluated.(25)  
To make full use of the repeated data sampling, a longitudinal analysis with mixed models 
was used in both studies. Time-dependent covariates included in the model were height and 
age in Study 3, and in Study 4 weight was also included. Fixed covariates were, in Study 3, 
term/preterm birth group, sex, and maternal smoking, and in Study 4 asthma group and sex. 
To assess potential different effects for the change over time, a preterm/term group-by-time 
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interaction term was used in Study 3 and an interaction term between the time and asthma 
group was included in the model in Study 4. 
4.6 ETHICAL APPROVALS 
 
Approvals were obtained from the Regional Ethical Review Board in Stockholm for all four 
studies: Preterm infant study (Study 1); 457/03, 6½ years preterm study (Study 2); 2010/520-
31/2 and amendment 2011/376-32, and the two BAMSE cohort-based studies (Studies 3 and 
4); 93:189 and amendments 02-420 and 210/1474-31/3.  
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5 RESULTS 
5.1 LUNG FUNCTION AT 6 AND 18 MONTHS AFTER PRETERM BIRTH: 
PRETERM INFANT STUDY (1) 
An overview of the participants at 6 and 18 months of age is presented in figure 5. 
 
Fig. 5. Overview of infants who met inclusion criteria and their 
participation during the study. 
 
 
Maximal forced expiratory flows were low, defined as below -1.96 z-scores, for the majority 
of children at both 6 and 18 months, except for VmaxFRC at 6 months of age. 
Cso was the only variable that differed statistically between BPD groups, where the 
moderate/severe BPD group presented with lower values than the mild BPD group at both 
time points, even though Cso was within normal limits for both BPD severity groups (except 
for moderate/severe BPD at age 6 months). The symptomatic group had significantly lower 
values for Cso, VmaxFRC and MEF50 at both 6 and 18 months compared to infants without 
respiratory symptoms (Table 1).  
Lung function development over time stratified by BPD group showed that z-scores for 
VmaxFRC significantly decreased for both groups.  
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Table 1 – Comparison of lung function expressed as z-scores at age 6 and 18 months in infants without or with reported symptoms. 
 
  No reported symptoms Reported symptoms  
  n median range n median range 
P-value comparing  
symptom groups 
6 months        
 VmaxFRC (z-score) 34 -1.50 -3.38;0.51 12 -2.23 -3.37;-0.88 0.006 
 FVC (z-score) 26 -0.97 -3.33:1.47 8 -1.24 -3.50;-0.86 0.155 
 FEV0.5 (z-score) 26 -2.33 -4.17;-0.24 8 -2.61 -5.31;-1.31 0.239 
 MEF50 (z-score) 24 -2.15 -4.71;0.28 7 -3.87 -5.18;-2.87 0.006 
 FRC (z-score) 35 -1.01 -2.64;0.98 15 -0.80 -2.12;1.26 0.325 
 Cso (z-score) 27 -1.63 -3.32;0.10 16 -2.8 -4.41;-0.33 0.004 
18 months        
 VmaxFRC (z-score) 22 -1.97 -3.34;-0.14 21 -2.69 -4.33;-1.45 0.001 
 FVC (z-score) 20 -1.92 -2.52;0.64 18 -2.11 -4.79;-0.53 0.152 
 FEV0.5 (z-score) 19 -2.14 -4.37;-1.32 17 -2.77 -5.02;-1.41 0.132 
 MEF50 (z-score) 21 -1.74 -5.33;-0.55 20 -2.97 -5.58;-0.93 0.048 
 FRC (z-score) 23 0.05 -1.74;2.16 18 -0.05 -1.45;2.75 0.431 
 Crso (z-score) 19 -0.44 -2.0;1.36 15 -1.23 -2.86;0.19 0.015 
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5.2 LUNG FUNCTION AT 6½ YEARS: SCHOOL-AGE PRETERM STUDY (2) 
 
In total, 89 % of the children contributed with any lung function assessment data and the 
success rates were 87 % for IOS and 54 % for spirometry, Figure 6. 
 
Figure 6. Overview of the preterm children and controls at 6½ years of age.  
 
Of the extremely prematurely born children, 14 % were born small for gestational age (SGA), 
and 90 % had been diagnosed with either moderate BPD (85 %) or severe BPD (15 %) in the 
neonatal period. Current wheeze or asthma medication was reported by 40 % of the preterm 
group and in 15 % of term controls.  
 
Lung function in children born extremely preterm 
Extreme preterm birth was associated with significantly lower values for all measured 
spirometric outcomes and significantly higher values of resistance and reactance measured 
using IOS, in comparison with controls. Significant reversibility of FEV1 (≥ 12 %, 
approximately 20 minutes after an inhaled dose of 400 micrograms of salbutamol through a 
valved spacer device) was seen in 28 % of preterm children and 10 % of controls. FVC was 
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below the 5
th
 percentile (lower limit of normal) of the normal population in 14 % of the 
preterm children and FEV1 was below the 5
th
 percentile in 23 %. 
 
Gestational age and lung function in children born extremely preterm 
Children born at 22 – 24 weeks of gestation had significantly lower values for all measured 
spirometric outcomes than children born at 25 – 26 weeks of gestation. The proportion of 
children born at 22 – 24 weeks with lung function below the lower limit of normal was 24 % 
for FVC and 44 % for FEV1. IOS results did not differ significantly between the two 
gestational age groups. 
 
Lung function and asthma-like disease 
Among the extremely preterm children, there was an association between reduced z-score for 
FVC (-0.6, 95 % CI -1.0;-0.1), FEV1 (-0.8, 95 % CI -1.3;-0.3), increased AX (0.6, 95 % CI 
0.1;1.6) and reported asthma-like disease in the previous 12 months (unpublished results). 
 
Lung function in preterm-children born SGA and AGA 
Lung function did not differ statistically between children born extremely preterm and SGA 
and those born AGA, except for a higher frequency dependence of resistance (R5-20) among 
children born SGA. 
 
Lung function in preterm children and association to severity of BPD 
There were no statistically significant lung function differences between the two levels of 
BPD, except for z-scores for lower ratio FEV1/FVC in preterm children with severe BPD 
compared with those with moderate BPD. 
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5.3 LUNG FUNCTION AT 16 YEARS AFTER MODERATE-TO-LATE PRETERM 
BIRTH (3) 
 
Of the 4 089 children in the original BAMSE cohort, 2 620 (64 %) and 2 605 (64 %) 
participated in the 8- and 16-year follow-ups, respectively. The participants and number of 
successful lung function tests in moderate-late-preterm and term groups are presented in 
Figure 7.  
 
 
Figure 7. Overview of the participants in the original BAMSE cohort and number of 
performed and accepted lung function tests at 8 and 16 years used for analysis. 
 
 
Lung function at 16 years 
Among subjects aged 16 years, negative associations between preterm birth and all 
spirometric indices, except FVC, were observed for both sexes (Table 2). In males, the 
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moderate-to-late preterm group demonstrated a FEV1 reduction of 4.0 % compared with term 
controls, and in females the reduction was 3.4 %.  
The IOS results in subjects aged 16 showed significantly higher estimated medians for R5, R5-
20, and AX
0.5
 in moderate-to-late preterm males compared with term males. Although a 
similar trend was seen for females, a significant difference was only seen for R5 (Table 2). 
To elucidate if the effect on lung function remained in those born closest to term, analysis 
was restricted to those born at 35 to 36 weeks of gestation. Differences compared with 
children born at term remained for spirometry results at age 16 (FEV1 -112 ml, 95 % CI -
217.6;-22.3) (unpublished results). 
 
Lung function from age 8 to 16 years  
There was an increasingly negative trend over time, between 8 and 16 years of age, for FEV1 
in preterm males compared with term males.  
 
Table 2. Differences in adjusted lung function between moderate-to-late preterm and term 
groups (adjusting for maternal smoking during pregnancy, height and age at examination). 
      Females             Males 
 Diff.  95 % CI P Diff. 95 % CI P 
 
Spirometry at 16 years 
FEV1 (ml) -116 -212;-20 0.02 -177 -329;-25 0.02 
FEV1 z-score* -0.29 -0.52;-0.05 0.02  -0.33 -0.61;-0.05  0.02 
MEF50 (ml/s) -409 -660;-159 0.001 -516   -879;-153 0.005 
FVC (ml) -6 -118;106 0.91 -65 -237;106 0.45 
FEV1/FVC (%) -2.9 -4.5;-1.3 < 0.001 -2.5 -4.4;-0.6 0.01 
       
IOS at 16 years 
R5 (Pa·L
-1
·s
-1
)  31.3 6.3;56.3 0.014 34.9 12.0;57.7 0.003 
R20 (Pa
.
L
-1.
s
-1
)
 
11.2 -9.7;32.1 0.292 15.6 -4.5;35.8 0.129 
R5-20 (Pa·L
-1
·s
-1
) 7.0 -4.8;18.8 0.243 20.9 9.8;31.9 < 0.001 
AX
0.5
 (Pa·L
-1
·s
-1
) 
0.5
  28.4   -10.6;67.4 0.154 49.9 16.8;83.1 0.003 
*Z-score according to GLI 2012(25). Z-score was adjusted for maternal smoking during 
pregnancy. Diff = difference.  
 
 
5.4 ASTHMA PHENOTYPES AND LUNG FUNCTION UP TO 16 YEARS OF 
AGE: EARLY CHILDHOOD ASTHMA STUDY (4) 
 
Children and adolescents taking part in the BAMSE study were at 16 years of age categorized 
into asthma groups at 16 years as follows: never asthma group, 1 928 individuals (82 % of the 
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eligible population); early transient asthma, 139 individuals (6 %); early persistent asthma, 61 
individuals (3 %); and late-onset asthma, 109 individuals (5 %). 
 
Asthma and spirometry at 16 years 
 
All asthma groups were associated with lower FEV1, FEV1/FVC and FEF50 values in 
comparison with the never asthma group at 16 years of age. The lowest values were seen for 
the early persistent group. 
 
Asthma and impulse oscillometry (IOS) at 16 years 
All asthma groups were associated with higher estimated means for R5 and R20 than the never 
asthma group. Figure 4 shows all percentiles for R5-20, an index  indicating heterogeneity in 
resistance distribution across the airway system. The distribution of R5-20 values was similar 
in the never asthma and transient asthma groups. The persistent asthma group showed a 
heterogeneous pattern including a wide range of R5-20 values and a skewed distribution with 
extremely large R5-20 values.  
 
Asthma and lung function change between 8 and 16 years 
We observed significantly less increase in FEV1 between 8 and 16 years for the early 
persistent and late-onset groups, but not for the early transient asthma group, as compared 
with the reference group. 
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Figure 4. Distribution of R5-20 values for the never asthma group (A) and difference 
between each asthma group and the “never asthma” group at all percentiles (B-D). 
Estimates at each percentile are shown as solid black lines with 95 percent confidence 
bands (shaded gray areas). The mean value (solid) and 95 percent confidence intervals 
(dashed) are shown as parallel black lines.  
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6 DISCUSSION 
6.1  LEVEL OF LUNG FUNCTION AFTER PRETERM BIRTH 
6.1.1 Maximal expiratory flows after preterm birth 
In Study 1, we found that patients at 6 and 18 months of age with either mild or 
moderate/severe BPD demonstrated low (< -1.96 z-scores) mean values for VmaxFRC, 
FEV0.5, and MEF50, with the exception of VmaxFRC at age 18 months for the mild BPD 
group. The vast majority of preterm infants had clinically significant (< -1.96 z-scores) 
reduced expiratory flows at 6 and 18 months of age. 
Similar infant lung function techniques have been used in other previous studies. Tidal RTC 
was used at approximately one year of age in a group of children born preterm (gestational 
weeks 29 – 36) without BPD and a reduction of VmaxFRC of -2.0 z-score was found.(74) Two 
other studies show similar reductions of VmaxFRC, -1.79 (40 % below -1.96 z-score) to -2.2 z-
score in moderate to severe BPD (75, 76) at 15 – 18 months of age. Filbrun et al. reported 
that FEV0.5 was on average -1.94 z-score at a mean age of 18 months in children with 
moderate to severe BPD.(77) Recently, infants with mild to severe BPD were shown to have 
FEV0.5 with 2.1 lower z-score at corrected age of 18 months of age as compared with 
published reference values.(78) 
 
In Study 2, we examined children at 6½ years of age with a history of moderate-to-severe 
BPD and found that 23 % of preterm children had FEV1 below the 5
th
 percentile (-1.64 z-
score). Among children born in gestational weeks 22 – 24, 44 % had values below the 5th 
percentile. The EPICure study investigated a similar group as our study. They reported an 
average reduction of -1.7 z-scores for FEV1 at 11 years of age in children earlier diagnosed 
with moderate-to-severe BPD.(33)  
 
In Study 3, we report on reduced maximal expiratory flows at 16 years of age in both females 
and males born moderate-to-late preterm (gestational weeks 32 – 36). The proportion of 
individuals with a FEV1 below the lower limit of normal (< -1.64 z-score) was, in males, 
significantly larger in the moderate-to-late preterm group than in the term group. Reports on 
lung function in adolescence in subjects born moderate-to-late preterm are sparse. Kotecha et 
al. found lower mid-expiratory flows and FEV1/FVC ratio at 14 – 17 years of age in the 
subgroup born in gestational weeks 33 – 34, but no difference compared with the term group 
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for the subgroup born in gestational weeks 35 – 36.(34) We also tested the effect on lung 
function in those born closest to term by restricting analysis to those born at 35 through 36 
weeks of gestation and found that differences compared with children born at term remained 
for spirometry results. 
 
In summary, in Study 1 and Study 2 we found clinically significant reductions of maximal 
expiratory flows in infancy and early school age and the levels of reductions are similar to 
findings in other studies. In Study 3, we found a 3 – 4 % reduction of FEV1 and more 
individuals than expected having values below the lower limit of normal after moderate-to-
late preterm birth. To our knowledge, Study 2 is the first to report on lung function results 
associated with the level of extreme preterm birth, showing that within the group of children 
born extremely preterm, the length of pregnancy matters for lung function development in 
childhood.  
To clarify the possible clinical implication of the lung function reduction after preterm birth, 
a comparison with natural age-related decline is presented. Natural age-related decline of 
FEV1 in adulthood has been calculated to be on average 21 ml/year in females and 27 ml/year 
in males.(79) The difference measured, for the whole preterm group at 6½ years (330 ml) in 
Study 2, would correspond to approximately 12 – 15 years of preterm natural lung function 
decline, depending on sex. Further, if tracking of lung function is assumed, the estimated 
reduction difference of -1.2 z-score at 6½ years in Study 2 equals 650 ml in an adult male 
(180 cm), suggesting approximately 24 years of expected preterm decline. Using the same 
assumption after moderate-to-late preterm birth, the low FEV1 at 16 years (177 ml) in 
moderate-to-late preterm males corresponds to a natural decline in adulthood of 7 years. If 
these predictions have a corresponding predictive value on life expectancy, can only be 
determined in long-term follow-up studies. 
   
6.1.2 Lung volumes after preterm birth 
In Study 1, plethysmographically measured FRC values were within normal range at both 6 
and 18 months of age. FVC, measured using raised RTC, was on average lower or borderline 
lower than expected at 18 months of age. Hofhuis et al. found FRCpleth to be within normal 
range (-0.6 z-score) in moderate-to-severe BPD at approximately 15 months of age.(76) 
Fakhoury et al. related FRC to ml per body weight (suggested normal range 16 – 26 ml/kg) 
and reported normal values at similar ages.(75) However, lung volumes measured using the 
gas dilution technique (Helium) showed lower FRCHe in children with BPD compared with 
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non-BPD or healthy preterm.(80, 81) Hilgendorf et al. showed that FRCpleth was reduced near 
term in children with BPD and further reduced after administration of beta2-agonist, 
suggesting over-inflation after preterm birth.(82) A study combining gas dilution techniques 
and whole body plethysmography in the same infants reported higher FRCpleth than FRCgas in 
follow-up of infants with a history of BPD, which also suggested over-inflation and gas 
trapping in infants with BPD.(83) This notion is supported by results in a study that used 
raised RTC and whole body plethysmography to calculate fractional lung volumes (TLC and 
RV) at approximately 18 months of age.(77) They found FVC and TLC to be normal low, but 
the RV/TLC ratio to be high.  
Since FRC is dynamically maintained in infants with obstructed airways, as could be 
assumed to be the case in infants with BPD, plethysmographically measured FRC may 
remain normal-to-high. Hence, it is possible that FRC measured plethysmographically, as in 
Study 1, cannot reflect trapped gas in the premature child, thus overestimating lung volume 
due to an obstructive pattern. 
 
In Study 2, the reduction of the measured volume among preterm children (gestational weeks 
22 – 26) was modest but significant compared with controls (term). Follow-up at school age 
has shown varying results for FVC in other studies. The EPICure study, which included a 
cohort with similar level of preterm birth as that in Study 2, found similar significant 
reduction of FVC, -0.8 z-score.(84) Studies that included a wider range of preterm birth 
subjects showed no significant differences in FVC between the preterm and term groups.(85-
87) However, normal TLC and increased RV/TLC ratio was seen in those studies, indicating 
an obstructive pattern. 
 
In Study 3, the children born moderate-to-late preterm had normal FVC values, no different 
to term controls at 16 years of age. This supports findings by other groups.(34, 88)  
 
In summary, lung volumes after preterm birth are normal or normal low and reported 
reduction in FVC is more likely to be a sign of airway collapsibility during exhalation than 
pulmonary restrictivity in children born very or extremely preterm. A possible explanation for 
this functional pattern could be loss of elastic recoil, altered airway wall mechanics and 
altered alveolarization in early life seen after preterm birth. 
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6.2 BPD SEVERITY IN RELATION TO LUNG FUNCTION 
 
The definition of BPD published in 2001 based on the NICHD/NHLBI workshop suggests 
three levels of severity for BPD: mild, moderate/severe and severe disease.(32) In the 
neonatal period, the grades of BPD severity have been found to be associated with neonatal 
comorbidities, longer hospital stay and higher gestational age at discharge, showing the 
usefulness of this definition.(89) A validation of the definition found an association to more 
severe disease and the use of pulmonary medication at 18 – 22 months of age.(90) Most 
studies on lung function after preterm birth compare the different definitions of BPD with 
individuals born at term or non-BPD and do not investigate the effect of BPD severity. 
Generally, those studies confirm significantly reduced lung function from infancy to 
adulthood among those with BPD diagnosed in the neonatal period.(9, 84, 91, 92) 
 
We used the consensus definition for BPD severity in Study 1 and Study 2. In Study 1, the 
only significant difference in lung function at 6 and 18 months of age was lower Cso in the 
moderate/severe group compared with the mild BPD group. Overall, maximal expiratory 
flows measured using RTC-technique were low (< -1.96 z-scores) for both groups at both 
time points, with the exception for VmaxFRC at age 18 months for the mild BPD group.  
 
In Study 2, we compare lung function  between moderate and severe BPD groups. Mild BPD 
was not considered in Study 2, due to the low incidence of mild BPD. Except for lower 
FEV1/FVC z-scores in children diagnosed in the neonatal period with severe BPD than in 
those diagnosed with moderate BPD, lung function at 6½ years of age did not vary in relation 
to severity of neonatal BPD. This was true for both spirometric and IOS variables. However, 
we found significant associations between gestational age and reduced lung function 
measured using spirometry, but not using IOS. Studies investigating lung function at follow-
up show conflicting results in relation to BPD severity. Hjalmarson et al. found lower FRC 
and less efficient gas mixing in severe BPD compared with less severe forms at 9 – 10 
months of age. A study from our hospital performed a follow-up at 6 – 8 years of age after 
preterm birth, showed significantly lower lung function in severe BPD compared with 
mild/moderate disease.(93) Large differences in percent of predicted FEV1 were reported 
between mild and more severe BPD groups at follow-up at 11 – 17 years of age in a cohort of 
children born in the 1980s and treated at a large tertiary center.(94) Results from a study 
using RTC methods during the first year of life indicate a non-significant association to BPD 
severity, in agreement with our findings.(95) A meta-analysis including follow-up studies of 
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subjects born between 1964 and 2000 at 24 – 36 weeks of gestation reported average FEV1 
reductions of 16 % associated with mild BPD and 19 % for moderate to severe BPD.(3)  
The lack of clear differences in lung function at follow-up in relation to BPD severity in 
Study 1 and Study 2 could be due to the fact that all children in both studies were very or 
extremely prematurely born, thus all having altered alveolarization due to prematurity. In 
fact, the groups in Study 1 were similar in regards to most background variables. This could 
indicate limited prognostic utility for BPD diagnose in this respect due to multifactorial 
etiology and difficulties in early identification of the disease. A limitation of the diagnostic 
criterion of BPD and BPD severity is the need of supplemental oxygen as a proxy for disease 
severity. Walsh et al. have reported a physiologic definition of BPD by a standardized timed 
room-air challenge (96, 97) that is recommended in Sweden since 2014 by the National board 
of Health and Welfare. However, the length of time for supplemental oxygen therapy and 
targeted oxygen saturation level could be a function of the immaturity of the child or of the 
local policies of individual units as reflective of lung pathology during the time of our studies. 
Further, mode of oxygen delivery, medications and possible upper airway obstruction may 
also influence gas exchange. It could be questioned if the histopathology of BPD, which the 
surrogate marker of oxygen need is thought to indicate, is not dichotomous but rather a 
continuous graded condition. Long-term pulmonary outcomes and supplemental oxygen at 
post menstrual age of 36 weeks have shown low values of sensitivity and specificity in some 
studies and might therefore be falsely related.(90, 98) Finally, even the most conservative 
definition of BPD, supplemental oxygen 28 days before gestational week 36 or at day 28, has 
been shown to be insufficient as a predictor due to low sensitivity for long-term pulmonary 
outcome.(93, 99)    
 
In summary, our results suggest that early BPD classification provides limited information on 
future lung function after preterm birth and other specific risk factors and mechanism for lung 
function development should be sought. To what extent early measured lung function could 
contribute needs further investigations. 
 
6.3 LONGITUDINAL ANALYSIS OF EXPIRATORY FLOWS AFTER PRETERM 
BIRTH AND EARLY BRONCHIAL OBSTRUCTIVE SYMPTOMS 
In Study 1, measurements of maximal expiratory flows showed persistently reduced values 
without catch-up from 6 to 18 months of age for both BPD and non-BPD groups. In fact, 
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VmaxFRC measured using tidal RTC decreased significantly at follow-up compared with 
reference values, while FEV0.5 remained at the same level of reduction.  
Serial measurements have been performed in a number of studies during the first years of life 
after preterm birth. A decline of VmaxFRC was also seen during the first year in children with 
moderate-to-severe BPD and in healthy children born preterm.(74, 76) Fakhoury et al. 
performed measurements at 6, 12 and 24 months and reported no change over time in mean 
z-score VmaxFRC in children with moderate-to-severe BPD.(75) The raised RTC technique 
expiratory flows in healthy preterm and children with BPD were low compared with term 
controls and no catch-up of lung function was seen in any of these three studies during 
infancy or early childhood.(77, 78, 100)  
 
Generally, these findings during infancy in our studies and others support the notion of 
tracking of lung function seen in older children and adolescents after very and extreme 
preterm birth.(92, 101, 102) The difference in development of variables from the tidal volume 
and raised volume RTC seen in our studies and others could indicate that VmaxFRC and 
FEV0.5 do not represent the same airway impairment. However, it is also possible that the 
difference is attributable to the reference values used, as suggested by Lum et al.(103) 
 
In Study 3, moderate-to-late preterm females and males showed no catch-up growth of lung 
function from 8 to 16 years of age. Instead, the negative effects were augmented between age 
8 and 16 years in males. Only two previous studies have longitudinally addressed lung 
function development after moderate-to-late preterm birth into school age and adolescence. 
Kotecha et al. found catch-up of FEV1 from 8 – 9 to 14 – 17 years of age in the subgroup of 
children born in gestational weeks 33 – 34.(34) A follow-up by Narang et al. from mid-
childhood (7 – 9 years) into young adulthood stated that there was no evidence of airway 
obstruction at 21 years of age in a cohort including participants born in gestational weeks 27 
– 37 who, at 7 – 9 years of age, had demonstrated reduced FEV0.75.(88) In a meta-analysis 
that included 24 birth cohorts, particularly late preterm, lung function was negatively 
associated with preterm birth across the full range of prematurity (< 37 weeks).(104) 
 
In Study 4, longitudinal lung function was compared from 8 to 16 years of age between 
asthma groups and the never asthma group. The two active asthma groups (early persistent 
and late-onset asthma) had significantly lower increases of FEV1. This was seen to a lesser 
extent in those with early transient asthma and reached significance only for mid-expiratory 
flows (MEF50). Similar findings were seen in a Norwegian study also identifying both active 
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asthma and asthma in remission to be associated with less increase of FEV1 during 
adolescence.(105) The Melbourne study found a negative lung function development from 12 
to 18 years for active asthma (early persistent and late-onset), but not for early transient 
asthma, which was suggested to be a benign disorder.(106) 
 
In summary, Study 1, Study 3 and Study 4 support the recognized concept of lung function 
tracking from birth to adolescence.(26) There were no catch-up of lung function seen in the 
first two years of life after very and extreme preterm birth, or from 8 to 16 years after 
moderate-to-late preterm birth or in asthma phenotypes during that same age span. In fact, the 
difference in lung function compared with controls was augmented after moderate-to-late 
preterm birth and in active asthma suggesting a ―two-hit‖ model including an insult early in 
life and ongoing processes. Decreasing FEV1/FVC ratios in young adults after very and 
extreme preterm birth seen in two other studies (92, 102), particularly in BPD, indicate that 
similar processes might continue after adolescence and need to be further investigated into 
adulthood.  
 
6.4 ASPECTS OF AIRWAY MECHANICS IN RELATION TO PRETERM BIRTH 
AND EARLY BRONCHIAL OBSTRUCTIVE SYMPTOMS 
6.4.1 Compliance of the respiratory system (Crs) after preterm birth 
In Study 1, Cso was the only measured lung function variable that was associated with BPD 
severity. It was also associated with respiratory symptoms. Except for infants with 
moderate/severe BPD and infants reporting symptoms at 6 months, measured values were 
within normal range and increased with age. Low compliance of the respiratory system in the 
neonatal period after preterm birth has been shown to be associated with BPD severity in 
other studies.(81, 107) Improvements during infancy and normalization compared with the 
control group are shown in those studies. Hjalmarson et al. and Schmalisch et al. found lower 
values in BPD, but after normalization for lung volume the significance disappeared. 
However, both studies used FRCHe, which has been shown to be lower in BPD than in non-
BPD. In our study, we used FRCpleth, which also includes trapped gas, making this 
comparison difficult. We compared with published reference values that take gestational age 
and body length into account.(69) For completeness, we also normalized values for weight, 
which did not change the conclusion (not published). A relationship between early measured 
Cso and wheezing illness and asthma during childhood has been shown in studies after term 
birth.(108, 109) The underlying pathophysiological mechanism for reduced Cso is complex, 
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involving the total respiratory system and is affected by alveoli as well as bronchi and chest 
wall. A possible explanation for why early measured Cso is associated with both BPD severity 
and respiratory symptoms is that hyperinflation, which stiffens the lungs, and the level of 
alveolarization, both lower respiratory compliance.   
 
In summary, compliance of the respiratory system measured in both sedated and un-sedated 
infants early in life, has been shown to be related to later lung function and respiratory 
symptoms and is therefore suggested to be tested as a marker of pulmonary outcome after 
preterm birth. 
6.4.2 Impulse oscillometry after to preterm birth and in relation to asthma 
phenotypes 
In Study 2, airway mechanics measured using the IOS technique showed higher values for all 
indices (R5, R5-20, AX) among preterm children as compared with controls. IOS variables 
were not different between the two preterm groups (gestational weeks 22 – 24 and 25 – 26). 
In follow-up studies of children, with and without BPD, IOS results distinguished between 
preterms and term controls as well as between preterm groups with and without BPD.(110) 
(93) Both studies report some concordance for IOS variables and FEV1, however not for the 
same indices. In our study, almost all participants had either moderate or severe BPD, making 
comparison difficult. We can only speculate into the reasons for a lack of association between 
the extreme preterm groups and IOS indices, in despite of significant spirometric differences. 
Perhaps IOS has lower sensitivity to discriminate the affected lung region in the most preterm 
individuals from the overall effect on airways seen after preterm birth. Or, since IOS is 
performed during tidal breathing without effort, airway closure induced by deep breaths or 
forced expirations, as during spirometry, will not interfere with the measurement.  
 
In Study 3, IOS results at age 16 showed significantly higher estimated medians for R5, R5-20, 
and AX
0.5
 in moderate-to-late preterm males compared with term males. Although a similar 
trend was seen for females, a significant difference was only seen for R5, despite significant 
spirometric differences also between moderate-to-late preterm and term females. To our 
knowledge, this is the first study using IOS in follow-ups after moderate-to-late preterm birth. 
 
In Study 4, the indices suggested to mirror peripheral airways R5-20 had a higher estimated 
mean in both active asthma groups compared with the never asthma group. It was also shown 
that the heterogeneity of resistance measured over the airway system was not different 
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between never asthma and early transient asthma. However, both active asthma groups, 
particularly the early persistent group, showed skewed distributions with very high values in 
the 90
th 
percentile. The notion that respiratory mechanics measured using IOS could give 
additive information compared with spirometric values in active asthma has been shown in 
studies addressing asthma treatment, asthma control and severity also including bronchial 
hyper-reactivity without respiratory symptoms, thus supporting our findings.(111, 112) 
 
In summary, Study 2, Study 3 and Study 4 show that for the active asthma phenotypes and 
the asthma-like syndrome seen after preterm birth, all being bronchial obstructive entities 
associated with increased smooth muscle airway tone and bronchial hyper-reactivity, the IOS 
technique has the potential to identify reactive airways. Frequency dependence of resistance 
(fdR, an index of bronchial obstruction) and AX (sensitive to peripheral bronchial 
obstruction) both showed increased values after preterm birth and in active asthma 
phenotypes groups, but not early transient asthma, despite reduced lung function in all groups 
studied. Hence, the mechanism for bronchial obstruction is different in the early transient 
asthma phenotype group compared to both active asthma and in the bronchial obstructive 
disease seen after preterm birth. 
Indeed, since the success rate of IOS measurements was also higher than conventional 
spirometry, primarily because this technique only requires passive cooperation from 
investigated subjects, it makes IOS a feasible technique particularly in children too young to 
perform spirometry.  
 
6.5 CLINICAL SYMPTOMS IN RELATION TO LUNG FUNCTION AFTER 
PRETERM BIRTH 
In Study 1, a third of infants reported respiratory symptoms at 6 months and the proportion 
increased up to almost half at 18 months of age. In contrast to the modest association between 
BPD severity and lung function, we found a clear association between reported respiratory 
symptoms and reduced lung function. Both lung mechanics (Cso) and lung function measured 
with TVRTC and RVRTC techniques showed significantly lower values among those 
reporting symptoms at both 6 and 18 months of age. Associations between respiratory 
symptoms and lung function after very and extreme preterm birth have only been investigated 
in a few studies during early childhood. Fakhoury et al. that showed lower VmaxFRC at 6 
(but not at 12 and 24) months of age among those who reported cough but not wheeze, and 
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Robin et al. found that recurrent wheezing was not associated with reduced lung function, 
except increased RV among the extreme preterm children.(75, 91) 
 
In Study 2, 40 % of children born preterm, compared with 15 % of controls, reported 
respiratory wheeze or use of asthma medication (asthma-like disease) in the last 12 months 
before follow-up at 6½ years. Within the preterm group, there was an association of 
asthma-like disease to lower lung function measured using spirometry (lower z-scores for 
FEV1 and FVC) and altered airway mechanics (higher AX). The EPIcure study reported 
that 25 % of extreme preterm children at 11 years of age had a current diagnosis of 
asthma.(84) They also studied the association between lung function and respiratory 
morbidity (wheeze ever) using spirometry, inert-gas washout and plethymography. They 
found associations to FEV1, FEV1/FVC ratio and specific resistance, but not to LCI or 
RV/TLC. The latter three are thought to represent more peripheral airways.(33) 
 
In Study 3, females born moderate-to-late preterm reported more respiratory symptoms at 
both 8 and 16 years of age than females born at term, in spite of less reduced lung function 
compared with term females than preterm males with term males. Respiratory symptoms 
were, as expected, negatively associated with lung function in the whole cohort but not within 
the moderate-to-late preterm group. Gender differences in respiratory health at 19 years of 
age have been reported after preterm birth and are well recognized in the general term 
population.(113, 114) It is suggested that this could be explained by different patterns of lung 
growth between genders. Males have smaller airways in relation to lung size before puberty 
and this change in puberty makes males less prone than females to respiratory symptoms as 
adults. However, moderate-to-late preterm females reported more respiratory symptoms 
already before puberty in our study, thus making this explanation less probable in the group 
of moderate-to-late preterm children.    
 
In Study 1 and Study 2, respiratory morbidity such as wheeze and asthma-like symptoms 
during infancy and childhood were associated with lung function decrements seen after very 
and extreme preterm birth. This was not seen after moderate-to-late preterm birth in late 
adolescence. The full nature of altered airways and lung parenchyma is not completely 
understood and needs to be further investigated. However, lung function tests in follow-up 
after very and extreme preterm birth could be suggested to identify individuals at risk of 
respiratory morbidity and possible treatment. 
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6.6 LIMITATIONS AND STRENGTHS  
The major strength of this thesis is that the included studies are based on data collected 
prospectively.  
Study 1 and Study 2 included the vast majority of infants with BPD or the most extremely 
preterm children and there was low loss to follow-up, both facts reducing the risk of selection 
bias. In the two studies based on the BAMSE cohort, the size and limited loss to follow-up 
minimizes random errors. In those two studies, a selection bias could have occurred at 
recruitment (75 % of eligible children included) and at follow-up. To evaluate possible 
selection bias at follow-up, study populations in Study 3 and Study 4 were compared with the 
original BAMSE cohort. With respect to population characteristics, the group of children who 
provided lung function data in Study 3 did not differ to any major extent from the original 
cohort. In Study 4, individuals who participated in the clinical testing were more often 
female, had more parental atopy and less maternal smoking during pregnancy than those who 
did not participate, which might to some extent limit the generalizability. 
 
Gestational age was obtained from the Swedish Medical Birth Registry and in more than 95 
% of the pregnancies gestation was determined using ultrasound. The narrow border between 
gestational age groups could introduce a risk of non-differential misclassification, however 
that would likely result in an underestimation of the true differences in lung function between 
the groups. 
 
A limitation and a possible random error of Study 1 is that there are different numbers of 
missing values for the measured variables, due to insufficient quality of measurement and 
preterm awaking (despite sedation). It was unlikely that this differed between groups and 
therefore we believe results were not affected. However, this reflects the challenges to 
perform lung function tests in sedated infants. In Study 2, the success rate for spirometry was 
low, but anticipated because of the young age at follow-up, which could introduce a selection 
bias if children with more severe respiratory morbidity where less successful in performing 
lung function tests. If so, we could have underestimated the differences between groups.  
 
A major limitation of Study 1 is the absence of a control group, which for ethical reasons was 
difficult to access.  
 
Misinterpretation due to inappropriate reference data cannot be excluded in Study 1.  
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A limitation of Studies 2 – 4 is that at early school age, mean spirometric z-scores were not 
centered at zero. Control groups had approximately 0.5 higher z-scores for spirometric 
variables at 8 years than the published reference population.(25) This could introduce an 
underestimation of the frequency of low lung function in our preterm groups in that age span. 
The effect is likely to be non-differential and not affect comparisons between groups.  
 
One of the major limitations in all but Study 2 is that examination after bronchodilation was 
not performed. Post-bronchodilator measurements would have been desirable in order to 
explore whether the observed impairments are due to static changes after remodeling of the 
airways, impaired airway growth or reversible airway obstruction.  
 
Finally, recall bias could have influenced the classification into symptom groups and 
prevalence of asthma and asthma-like disease due to the use of questionnaires at the different 
time points at follow-up.  
7 ETHICAL CONSIDERATIONS 
In Study 1, all parents were informed of the purpose of the procedures and informed consent 
was obtained for all measurements. To perform ILFT, the child has to be sedated by orally 
administrated choral hydrate, which has a bitter taste and could lead to some discomfort for 
the child. The sedation method is recommended by consensus publications for ILFT. During 
the time period of recruitment the infant lung function procedures used in the study were 
implemented as standard follow-up of children with BPD at our center. 
In Studies 2 – 4, lung function tests were performed in cooperation with the child/adolescent, 
who was awake. Lung function tests do not involve large efforts or painful procedures. The 
lung function methods used are well standardized and common in normal clinical setting 
worldwide. 
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8 CONCLUSIONS 
 The majority of very and extreme preterm born children have expiratory flow values 
below the normal range at infancy. At early school age, this is less pronounced but 
still indicates a significantly reduced lung function. Lung function in adolescence 
after moderate-to-late preterm birth is lower than after term birth. 
 Children born very and extreme preterm have impaired lung function compared with 
published reference values and term controls, but early staging of BPD severity is 
insufficent as a prognostic marker of lung function. 
 Early measured lung function after preterm birth is associated with respiratory 
symptoms during infancy and childhood, and therefore suggested to identify infants at 
risk of respiratory mobidity. 
 No catch-up of lung function was seen in the first two years of life after very and 
extreme preterm birth, or from 8 to 16 years after moderate-to-late preterm birth. This 
was also observed in early childhood asthma phenotypes between 8 and 16 years of 
age. 
 Childhood asthma phenotypes including early transient disease, based on onset and 
duration of symptoms, were all negatively associated with FEV1 at 16 years of age.   
 The bronchial obstructive pattern, measured by spirometry and IOS, seen in 
adoloescense in the group with early transient asthma is different than the obstructive 
patterns seen in active asthma phenotype groups and after preterm birth. However, the 
bronchial obstructive pattern in the active asthma phenotypes at 16 years and after 
preterm birth at 6 and 16 years of age show similarities.  
 IOS, which is suitable for lung function measurement in children too young to 
perform spirometry, may identify children with low lung function after preterm birth 
and those with active asthma.  
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9 CLINICAL REMARKS 
 The absence of catch-up growth of lung function after preterm birth or in early 
asthma phenotypes indicates that low initial lung function after preterm and term 
birth is associated with tracking of reduced lung function during childhood.   
 Children born moderate-to-late preterm are at risk of reaching adulthood with a 
modest, but concerning, reduction of lung function. 
 Both time of onset and persistance of asthma symptoms are associated with lung 
function impairment.  
 The combination of data from spirometry and IOS provides new insights about 
asthma phenotypes and indicates similarities between active asthma and asthma-
like disease after preterm birth, which need to be further investigated.  
 Preterm birth interrupts normal lung development, which affects lung function 
later in childhood. Measurements of lung function may identify children at risk 
for respiratory morbidity and provide insights into long-term sequel of preterm 
birth.  
 Regular assessments of lung function from infancy, during childhood and 
possibly through life, is therefore suggested to be an important tool when 
monitoring individuals born preterm, including moderate-to-late preterm birth.  
 Intervention studies on treatment of asthma-like symptoms after preterm birth are 
highly warranted and the understanding of lung function in infancy and during 
growth could improve the basis for such research. 
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10 SVENSK SAMMANFATTNING 
Bakgrund: Lungornas utveckling påverkas under fostertiden och barndomen av tidpunkten, 
längden, typen och intensiteten av diverse händelser, sjukdomsprocesser och 
omgivningsfaktorer. En vanlig sådan händelse är förtidig födsel. Ungefär 11 % av alla 
graviditeter är kortare än 37 fullgångna graviditetsveckor, vilket är definitionen på förtidig 
eller prematur födsel. Några få procent av alla födslar är mycket förtidiga (tidigare än 32 
veckor). Incidensen för den mest extremt förtidigt födda gruppen, tidigare än 27 veckor, var 
3/1 000 födda i den svenska multicenterstudien EXPRESS (Extremely Preterm Infants in 
Sweden Study).   
 
Bronkopulmonell dysplasi, eller också benämnt kronisk lungsjukdom efter förtidig födsel, är 
det kanske vanligaste och allvarligaste kroniska resttillståndet efter extrem förtidig födsel. I 
EXPRESS-studien hade nära alla deltagare diagnostiserats neonatalt med någon grad av 
sjukdomen, varav 73 % med måttlig eller svår BPD. Uppföljningar från spädbarnsåldern till 
ung vuxen ålder har visat kvarstående luftvägssjuklighet och nedsatt lungfunktion. Den 
kliniska bilden av luftvägssjukdomen efter spädbarnstiden uppvisar en astmalik bild 
inkluderande återkommande pip och väs i luftrören, ökad bronkiell hyperreaktivitet samt 
obstruktiv lungfunktionsnedsättning. Man bör dock inte använda begreppet astma för detta 
tillstånd eftersom astma i allmänhet definieras som en inflammatorisk luftvägssjukdom. 
Lungsjukdomen efter förtidig födsel är emellertid inte associerad med luftvägsinflammation.  
Astma och astmalika tillstånd är mycket vanliga under barndomen också efter födsel i 
fullgången tid.  
 
Över 30 % av alla barn i befolkningen har haft enstaka eller återkommande episoder av 
astmalika symtom, främst vid luftvägsinfektioner, under sina första levnadsår. För 
majoriteten är prognosen god och mindre än en tredjedel har kvar problemen efter sex års 
ålder. I syfte att beskriva förlopp av astmasjukdom, välja och utveckla behandlings- och 
preventionsstrategier, har flera astmafenotyper beskrivits. Dessa fenotyper är oftast 
retrospektivt beskrivna och har alltså föga värde för klinkern som står med ett barn med 
astmalika symtom framför sig. Att identifiera kliniska astmafenotyper med tillräckligt god 
sensitivitet och specificitet i klinisk vardag för att avgöra prognos och välja behandling, har 
visat sig vara svårt, men sannolikt kan information om lungfunktion, genetik och 
omgivningsfaktorer vara en väg framåt. Den vanligaste fenotypen av småbarnsastma är den 
med tidig debut och oftast symtomfrihet efter 4 – 5 års ålder; s.k. transient early 
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asthma/wheeze (ung. ‖tidig övergående astma‖) som vi på svenska ofta kallar ‖övergående 
förkylningsastma‖. Övergående förkylningsastma har visats ge låg lungfunktion redan under 
spädbarnstiden och kvarstående lägre lungfunktion som ung vuxen, trots att 
luftvägssymtomen upphör redan under småbarnstiden. Huruvida det astmalika tillståndet som 
ses efter förtidig födsel ska betraktas om en unik astmafenotyp kan ifrågasättas. Likheten 
mellan övergående småbarnsastma och tillståndet efter förtidig födsel (tidigt nedsatt 
lungfunktion, ej typisk allergisk inflammation) kan göra jämförelser intressanta. 
 
Huvudfrågeställningar 
 Hur påverkas lungfunktionen från spädbarnstiden till adolescensen i relation till 
förtidig födsel och tidigt utvecklad astma i barndomen?   
 Kan likheter och skillnader i lungfunktion hos förtidigt födda individer och personer 
med olika astmafenotyper i barndomen ge information om mekanismerna bakom 
luftvägsobstruktionen hos dessa tillstånd? 
 
 
Delstudie 1: Lungfunktion vid 6 och 18 månader efter förtidig födsel i relation till 
svårighetsgrad av bronkopulmonell dysplasi (BPD) 
Femtiofem extremt förtidigt födda barn med olika grader av BPD undersöktes med flera olika 
typer av lungfunktionsmetoder under inducerad sömn vid 6 och 18 månader efter födseln.  
Majoriten av barnen hade vid både undersökningstillfällena definitionsmässigt nedsatta 
expiratoriska utandningsflöden (< -1.96 standardavvikelser). Utom lägre compliance av 
respiratoriska systemet (ung. elastiska egenskaper), som var lägre hos barn med måttlig/svår 
BPD än hos lindrig BPD, fann vi inga skillnader i lungfunktion mellan svårighetsgraderna. 
Emellertid fann vi statistiskt signifikant sämre lungfunktion i flertalet av de uppmätta 
lungfunktionsmått hos de barn för vilka luftvägssymtom rapporterades vid 6 och/eller 18 
månader, jämfört med hos dem som var symtomfria.  
 
Slutsatsen av undersökningen var att extremt förtidigt födda barn hade låg lungfunktion vid 6 
och 18 månader utan klar relation till BPD-grad och att luftvägssymtom var tydligt 
associerade med sämre lungfunktion. 
 
Delstudie 2: Lungfunktion hos 6 år gamla barn som fötts extremt tidigt - en 
populationsbaserad kohortstudie (EXPRESS) 
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Drygt hälften av deltagarna i den nationella svenska multicenterstudien EXPRESS, som 
inkluderat alla extremt förtidigt födda barn i Sverige (< 27 födelsevecka) inbjöds vid 6 års 
ålder till studien. Vid uppföljningen gjordes lungfunktion med två metoder (spirometri och 
impulsoscillometri). Lungfunktionsdata från 153 förtidigt födda barn och 157 kontrollbarn, 
födda i fullgången tid, kunde analyseras.  
Bägge metoderna visade statistiskt signifikant nedsatt lungfunktion för den prematurfödda 
gruppen. Undergruppen av barn födda under födelsevecka 22 till och med 24 påvisades ha 
sämst lungfunktion. Nära hälften av dessa hade ett forcerat expiratoriskt flöde vid 1 sekund 
(FEV1) under den statistiska femte percentilen (förväntat 5 %) och en fjärdedel hade en 
maximal utandad volym (FVC) under samma percentil. Signifikant förbättring av 
lungfunktionen sågs hos 28 % av de prematurfödda efter inandning av luftrörsvidgande 
läkemedel jämfört med 10 % av konrollerna. Om barnet var fött med låg födelsevikt (small 
for gestational age, SGA) eller med svår BPD gav det bara marginellt sämre lungfunktion 
jämfört med vid normal födelsevikt respektive lägre allvarlighetsgrad av BPD. 
 
Slutsatserna var att ett stort antal förtidigt födda barn har kliniskt relevant nedsatt 
lungfunktion vid 6 års ålder, att resultaten visade att luftvägsbehandling bör övervägas och att 
fortsatta uppföljningar av lungfunktionen bör ske under uppväxten.  
 
Delstudie 3: Lungfunktion vid 8 och 16 års ålder efter måttligt förtidig födsel: En 
prospektiv kohortstudie. 
Vi använde data från BAMSE-kohorten, som ursprungligen hade 4 089 deltagare med 
prevalensen 4.8 % för gruppen måttligt till lindrigt förtidigt födda (födelsevecka 32 – 36). 
Lungfunktion med spirometriundersökning vid 8 och 16 år samt impulsoscillometri (IOS) vid 
16 års ålder användes vid analyserna. Totalt bidrog 2 621 deltagare, varav 149 prematurfödda 
och 2 472 fullgångna (födelsevecka 37 – 41) med lungfunktionsdata.  
Vid 16 års ålder hade båda könen statistiskt lägre lungfunktion mätt med spirometri (FEV1 
3,4 % lägre för flickor och 4 % lägre för pojkar). Andelen pojkar med lågt FEV1 (under femte 
percentilen) var vid 16 års ålder 15 % (kontroller 3,7 %). IOS-resultaten bekräftade lägre 
lungfunktion för pojkar, men för flickor sågs en trend som inte nådde statistisk signifikans. 
Longitudinell lungfunktion från 8 till 16 år visade att de prematurfödda barnen inte ökade sin 
lungfunktion (FEV1, MEF50, FEV1/FVC) jämfört med dem som fötts i fullgången tid. 
Skillnaden kvarstod för flickor, medan skillnaden ökade för pojkar. 
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Slutsatsen var att både flickor och pojkar födda bara några veckor före beräknad fullgången 
tid även i tonåren hade lägre lungfunktion, 3,4 % respektive 4 %, jämfört med dem som fötts 
i fullgången tid. Vidare sågs mellan 8 och 16 års ålder ingen relativ förbättring av 
lungfunktionen för de förtidigt födda.   
 
Delstudie 4: Astmafenotyper och lungfunktion upp till 16 års ålder – BAMSE-kohorten 
Liksom i delstudie 3 användes data från BAMSE-kohorten och lungfunktionsresultaten från 8 
och 16 års ålder. Baserat på enkätsvar (1-, 2-, 4-, 8- och 16-års-uppföljningarna) 
kategoriserades deltagarna i astmafenotyperna: ‖aldrig astma‖ (82 %), ‖tidig övergående 
astma‖ (6 %), ‖tidig kronisk astma‖ (3 %) samt ‖sent debuterande astma‖ (3 %).  
Vid 8-års-uppföljningen bidrog 1 832 deltagare med spirometriresultat och vid 16-års-
uppföljningen bidrog 2 056 med spirometriresultat och 2 453 med IOS-resultat. 
Spirometriresultaten visade att alla tre astmagrupperna hade statistiskt lägre lungfunktion vid 
16 års ålder jämfört med individer utan astma. IOS-resultaten vid 16 års ålder visade att båda 
grupperna med aktiv astmafenotyp hade statistiskt högre värden för R5-20 och AX (‖index‖ 
för perifer luftvägsobstruktivet) medan dessa värden inte skiljde sig mellan fenotypen ‖tidig 
övergående astma‖ och gruppen ‖aldrig astma‖. Vidare sågs ingen relativ förbättring av 
lungfunktion mellan 8 och 16 år för någon av astmafenotyperna. I stället sågs en ökning av 
skillnaderna för FEV1 för de aktiva astmafenotyperna jämfört med fenotypen som aldrig haft 
astma. 
 
Slutsatsen blev att oavsett astmafenotyp hade individer med astma någon gång under 
barndomen lägre spirometriskt mätt lungfunktion vid 16 års ålder. Ingen relativ förbättring av 
lungfunktionen mellan 8 och 16 år sågs jämfört med barn som aldrig haft astma. IOS-
resultaten visade att grupperna som hade astmafenotyper med aktiv astma var associerade 
med fynd som kan förklaras av obstruktivitet i små luftvägar. 
 
Konklusioner 
- Majoriteten av extremt förtidigt födda barn hade under spädbarnsperioden maximala 
expiratoriska lungfunktionsvärden som var under nedre gränsen för normalvärden. I 
tidig skolålder var detta mindre uttalat, men en påtaglig reduktion av lungfunktionen 
kvarstod. Lungfunktionen var, vid 16 års ålder, lägre för dem som var födda bara 
några veckor förtidigt jämfört med dem som fötts i fullgången tid.  
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- Tidig gradering av svårighetsgrad för BPD gav begränsad information om senare 
lungfunktion och är en otillräcklig markör för lungfunktionsutveckling under 
barndomen. 
- Tidigt mätt lungfunktion efter förtidig födsel var associerad med luftvägssymtom och 
kan därför identifiera individer med risk för luftvägssjukdom. 
- Alla undersökta astmafenotyperna hade vid 16 års ålder lägre lungfunktion än 
gruppen som aldrig haft astma. 
- Longitudinellt såg man ingen relativ förbättring av lungfunktionen under 
uppföljningsperioderna efter förtidig födsel eller efter tidig astmadebut. 
- IOS-metoden, som är enkel att använda på yngre barn som ännu inte kan genomföra 
spirometri, identifierar låg lungfunktion efter tidig födsel och individer som har 
astmafenotyper med aktiv astmasjukdom.  
 
Klinisk slutsats 
- Lungfunktionsmätning kan identifiera barn med risk för symtom från luftvägarna och 
kan öka kunskapen om framtida lungutveckling. Jag föreslår därför att förtidigt födda 
barn ska genomföra undersökningar av lungfunktionen tidigt och regelbundet, upp till 
vuxen ålder. 
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